JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

58 hedge funds and large institutions have $270M invested in Jounce Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$82.4M
2
+$34.8M
3
+$22.5M
4
PI
Pharmstandard International
Luxembourg
+$14.6M
5
OFM
Omega Fund Management
Massachusetts
+$12.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.34M
27
$1M
28
$880K
29
$767K
30
$732K
31
$670K
32
$445K
33
$391K
34
$385K
35
$279K
36
$278K
37
$273K
38
$271K
39
$256K
40
$229K
41
$212K
42
$195K
43
$177K
44
$141K
45
$140K
46
$121K
47
$99K
48
$87K
49
$80K
50
$74K
1
2
3